In August 14 on-line Proceedings of the National Academy of Sciences Susan Moir and colleagues from National Institute of Allergy and Infectious Diseases, Bethesda, US show that HIV viremia induces ...

It is likely that B-cell-derived regulatory IL-10 has evolved to serve distinct immune functions, and that these functions are in turn carefully regulated in a cell-subset- and context-dependent ...

When your doctor talks to you about your B-cell lymphoma, they'll tell you what type you have. It's an important piece of info to get, because each type of this cancer acts differently and has its ...

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal ...

There are two forms: Partial remission. Your B-cell lymphoma has gotten smaller, but it's still there. Usually the cancer has shrunk by half or more. Complete remission. Your doctor can't find any ...

Intravascular large B-cell lymphoma (IVLBCL) is a rare type of non-Hodgkin’s lymphoma. Its symptoms can vary, making it difficult to diagnose. The outlook for people with IVLBCL is typically poor.

have shown that rather than 'inheriting' their dependence on CARD11 from their normal cellular counterparts, addiction to CARD11 in a subset of ABC ... of germinal center B cell-like DLBCL biopsy ...

Among patients with relapsing multiple sclerosis, 450 mg of ublituximab could be safely infused in 30 minutes at week 24.

A pioneering study offers unprecedented insights into the bone immune microenvironment of type 2 diabetic mice, uncovering a ...